-
Mission launches Uribel
SAN ANTONIO Drug maker Mission Pharmacal has launched a treatment for urinary tract infections.
Mission announced the launch of Uribel (methenamine, sodium phosphate monobasic, phenyl salicylate, methylene blue and hyoscyamine sulfave) capsules, used to relieve local discomfort and inflammation associated with lower urinary tract infections, interstitial cystitis, painful bladder syndrome and urinary tract procedures.
-
AADE: Diabetes training programs can trim healthcare costs
CHICAGO A group that promotes education and awareness around diabetes is calling on the government and private insurers to use diabetes education as a cost-saving strategy.
The American Association of Diabetes Educators hopes to provide diabetes self-management training to patients with prediabetes and recommended that private insurers and Medicare include it as a covered benefit.